BMI and Contraceptives Affect New Age-, Sex-, and Puberty-adjusted IGF-I and IGFBP-3 Reference Ranges Across Life Span.
Charlott HörenzMandy VogelKerstin WirknerUta CeglarekJoachim ThieryRoland PfäffleWieland KiessJürgen KratzschPublished in: The Journal of clinical endocrinology and metabolism (2022)
BMI and CDs must be considered when assessing and interpreting the clinical relevance of IGF-I and IGFBP-3 measurements.